Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:CBLI
Delisted

Cleveland BioLabs Stock Price (Quote)

$0.240
+0.0060 (+2.56%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.202 $0.499 Friday, 27th May 2022 CBLI stock ended at $0.240. This is 2.56% more than the trading day before Thursday, 26th May 2022. During the day the stock fluctuated 8.70% from a day low at $0.230 to a day high of $0.250.
90 days $0.202 $1.06
52 weeks $0.202 $7.10

Historical Cleveland BioLabs prices

Date Open High Low Close Volume
Jun 15, 2016 $2.54 $2.65 $2.54 $2.61 5 340
Jun 14, 2016 $2.41 $2.57 $2.25 $2.57 6 956
Jun 13, 2016 $2.53 $2.64 $2.45 $2.47 8 544
Jun 10, 2016 $2.60 $2.62 $2.50 $2.61 9 298
Jun 09, 2016 $2.62 $2.62 $2.27 $2.60 42 402
Jun 08, 2016 $2.25 $2.69 $2.18 $2.59 90 501
Jun 07, 2016 $2.13 $2.24 $2.12 $2.23 27 695
Jun 06, 2016 $2.12 $2.17 $2.08 $2.10 14 262
Jun 03, 2016 $2.20 $2.20 $2.11 $2.13 1 868
Jun 02, 2016 $2.17 $2.24 $2.17 $2.19 6 611
Jun 01, 2016 $2.20 $2.29 $2.15 $2.18 7 896
May 31, 2016 $2.23 $2.24 $2.17 $2.24 2 949
May 27, 2016 $2.23 $2.24 $2.17 $2.21 4 155
May 26, 2016 $2.14 $2.26 $2.10 $2.22 11 660
May 25, 2016 $2.12 $2.19 $2.11 $2.14 9 112
May 24, 2016 $2.07 $2.15 $1.96 $2.15 14 456
May 23, 2016 $2.18 $2.18 $2.02 $2.07 4 508
May 20, 2016 $2.10 $2.31 $2.06 $2.14 81 125
May 19, 2016 $2.10 $2.12 $1.97 $2.10 10 672
May 18, 2016 $2.12 $2.31 $2.10 $2.10 5 296
May 17, 2016 $2.19 $2.19 $2.13 $2.13 2 085
May 16, 2016 $2.10 $2.21 $2.13 $2.13 7 406
May 13, 2016 $2.08 $2.31 $2.08 $2.10 8 664
May 12, 2016 $2.11 $2.25 $2.09 $2.10 11 312
May 11, 2016 $2.04 $2.10 $2.00 $2.09 8 210
Click to get the best stock tips daily for free!

About Cleveland BioLabs

Cleveland BioLabs Cleveland BioLabs, Inc., a biopharmaceutical company, focuses on developing pharmaceuticals designed to address diseases with unmet medical need. Its lead drug candidate includes Entolimod, a Toll-like receptor 5 (TLR5) agonist, which is used for the prevention of death from acute radiation syndrome, and is used as an oncology drug. The company is also developing CBLB612, a pharmacologically optimized synthetic molecule that structurally mimics n... CBLI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT